Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Beads
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Beads

[0007-CPX-100-10] Carboxyl Polystyrene Particle, Crosslinked, 2.5%w/v, 8.0-12.9µm - 10 mL
Carboxyl Polystyrene Particle, Crosslinked, 2.5%w/v, 8.0-12.9µm - 10 mL
376.00 € 376.0 EUR
[0007-CPX-200-10] Carboxyl Polystyrene Particle, Crosslinked, 2.5%w/v, 18.0-24.9µm, 10mL
Carboxyl Polystyrene Particle, Crosslinked, 2.5%w/v, 18.0-24.9µm, 10mL
566.00 € 566.0 EUR
[0007-CP-50-10] Carboxyl Polystyrene Particle, 5%w/v, 5.0-5.9µm - 10mL
Carboxyl Polystyrene Particle, 5%w/v, 5.0-5.9µm - 10mL
376.00 € 376.0 EUR
[0007-CP-20-10] Carboxyl Polystyrene Particle, 5%w/v, 2.0-2.4µm, 10mL
Carboxyl Polystyrene Particle, 5%w/v, 2.0-2.4µm, 10mL
239.00 € 239.0 EUR
[0007-CM-40-10] Carboxyl Magnetic Particle, 2.5%w/v, 4.0-4.5µm, 10mL
Carboxyl Magnetic Particle, 2.5%w/v, 4.0-4.5µm, 10mL
228.00 € 228.0 EUR
[0007-CM-300-10] Carboxyl Magnetic Particle, 1%w/v, 25-37 µm - 10mL
Carboxyl Magnetic Particle, 1%w/v, 25-37 µm - 10mL
501.00 € 501.0 EUR
[0007-CM-30-10] Carboxyl Magnetic Particle 2.5% w/v 3.0-3.9 µm,10 mL
Carboxyl Magnetic Particle 2.5% w/v 3.0-3.9 µm,10 mL
315.00 € 315.0 EUR
[0007-CM-60-10] Carboxyl Magnetic Particle (2.5% w/v , 6.0-8.0 µm ) - 10 mL
Carboxyl Magnetic Particle (2.5% w/v , 6.0-8.0 µm ) - 10 mL
419.00 € 419.0 EUR
[0007-CMPAK-4068-6K] Carboxyl Magnetic Blue Particle Array Test, 6 Peaks, 1E7/mL, 4.0-4.9µm - 6x1mL
Carboxyl Magnetic Blue Particle Array Test, 6 Peaks, 1E7/mL, 4.0-4.9µm - 6x1mL
429.00 € 429.0 EUR
[0007-CFP-2058-2] Carboxyl Fluorescent Pink Particle 1.0% w/v 1.7-2.2 µm - 2mL
Carboxyl Fluorescent Pink Particle 1.0% w/v 1.7-2.2 µm - 2mL
230.00 € 230.0 EUR
[0007-CFP-2052-2] Carboxyl Fluorescent Particle, Yellow, 1%w/v, 1.7-2.2µm - 2mL
Carboxyl Fluorescent Particle, Yellow, 1%w/v, 1.7-2.2µm - 2mL
267.00 € 267.0 EUR
[0007-CFP-00552-2] Carboxyl Fluorescent Particle, Yellow, 1%w/v, 0.04-0.08µm, 2ml
Carboxyl Fluorescent Particle, Yellow, 1%w/v, 0.04-0.08µm, 2ml
315.00 € 315.0 EUR
[0007-CFP-2066-2] Carboxyl Fluorescent Particle, CyBlue, 1%w/v, 1.7-2.2µm - 2mL
Carboxyl Fluorescent Particle, CyBlue, 1%w/v, 1.7-2.2µm - 2mL
267.00 € 267.0 EUR
[0007-CFH-5056-2] Carboxyl Fluorescent Nile Red Particle, High Intensity 0.5% w/v 5.0-5.9 µm, 2 ml
Carboxyl Fluorescent Nile Red Particle, High Intensity 0.5% w/v 5.0-5.9 µm, 2 ml
315.00 € 315.0 EUR
[0500-CMV-Null-RB] CMV Control  lentiviral Particle (RFP-Bsd), 1 x107 IFU/ml x 200ul
CMV Control lentiviral Particle (RFP-Bsd), 1 x107 IFU/ml x 200ul
365.00 € 365.0 EUR
[0007-BCP-100-5] Blank Calibration Particle, 5x10^6/mL, 8.0-12.9µm - 5mL
Blank Calibration Particle, 5x10^6/mL, 8.0-12.9µm - 5mL
314.00 € 314.0 EUR
[0007-TP-60-5] Biotin Polystyrene Particle, 1%w/v, 6.0-8.0µm - 5mL
Biotin Polystyrene Particle, 1%w/v, 6.0-8.0µm - 5mL
440.00 € 440.0 EUR
[0007-TP-08-10] Biotin Coated Polystyrene Particle - 10 mL
Biotin Coated Polystyrene Particle - 10 mL
419.00 € 419.0 EUR
[0007-VP-10-10] Avidin Polystyrene Particle, 5.0%w/v, 1.0-1.9µm - 10 mL
Avidin Polystyrene Particle, 5.0%w/v, 1.0-1.9µm - 10 mL
403.00 € 403.0 EUR
[0007-DIGP-20-2] Anti-Digoxigenin Coated Polystyrene Particle, 2.0- 2.4µm, 0.1%w/v, 2mL
Anti-Digoxigenin Coated Polystyrene Particle, 2.0- 2.4µm, 0.1%w/v, 2mL
412.50 € 412.5 EUR
  • 1
  • 2
  • 3
  • 4
  • 5

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)